Selling, General & Admin | 15.39 | 9.89 | 18.92 | 12.35 | 2.43 | |
Research & Development | 11.61 | 11.58 | 26.21 | 23.32 | 9.34 | |
Operating Expenses | 27 | 21.47 | 45.14 | 35.67 | 11.77 | |
Operating Income | -27 | -21.47 | -45.14 | -35.67 | -11.77 | |
Interest & Investment Income | 7.38 | 2.29 | 1.2 | 0.45 | - | |
Currency Exchange Gain (Loss) | -0.01 | 0.54 | -1.48 | -0.17 | 0.26 | |
Other Non Operating Income (Expenses) | - | - | - | -11.72 | - | |
EBT Excluding Unusual Items | -19.64 | -18.64 | -45.42 | -47.11 | -11.51 | |
Merger & Restructuring Charges | -3.36 | -18.81 | - | - | - | |
Gain (Loss) on Sale of Investments | 0.76 | 2.33 | 0.18 | -0.37 | - | |
Pretax Income | -73.9 | -35.12 | -45.24 | -47.48 | -20.67 | |
Net Income | -73.9 | -35.12 | -45.24 | -47.48 | -20.67 | |
Preferred Dividends & Other Adjustments | - | - | - | 4.55 | 2.29 | |
Net Income to Common | -73.9 | -35.12 | -45.24 | -52.03 | -22.95 | |
Shares Outstanding (Basic) | 48 | 27 | 26 | 12 | 2 | |
Shares Outstanding (Diluted) | 48 | 27 | 26 | 12 | 2 | |
Shares Change (YoY) | 78.47% | 2.57% | 114.60% | 460.40% | 31.72% | |
EPS (Basic) | -1.53 | -1.30 | -1.72 | -4.24 | -10.49 | |
EPS (Diluted) | -1.53 | -1.30 | -1.72 | -4.24 | -10.49 | |
EBIT | -27 | -21.47 | -45.14 | -35.67 | -11.77 | |